Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report
Allergy · 2023-07 · 78 (7) · 1758-1776
DOI: 10.1111/all.15740 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Allergy, online erschienen am 30.06.2023. Verfasst von Jean Bousquet und 59 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Allergology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Rhinitis, Asthma, Rhinitis, Allergic, Respiration Disorders. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Biomarkers for the diagnosis, treatment and follow‐up of patients with rhinitis and/or asthma are urgently needed. Although some biologic biomarkers exist in specialist care for asthma, they cannot be largely used in primary care. There are no validated biomarkers in rhinitis or allergen immunotherapy (AIT) that can be used in clinical practice. The digital transformation of health and health care (including mHealth) places the patient at the center of the health system and is likely to optimize the practice of allergy. Allergic Rhinitis and its Impact on Asthma (ARIA) and EAACI (European Academy of Allergy and Clinical Immunology) developed a Task Force aimed at proposing patient‐reported outcome measures (PROMs) as digital biomarkers that can be easily used for different purposes in rhinitis and asthma. It first defined control digital biomarkers that should make a bridge between clinical practice, randomized controlled trials, observational real‐life studies and allergen challenges. Using the MASK‐air app as a model, a daily electronic combined symptom‐medication score for allergic diseases (CSMS) or for asthma (e‐DASTHMA), combined with a monthly control questionnaire, was embedded in a strategy similar to the diabetes approach for disease control. To mimic real‐life, it secondly proposed quality‐of‐life digital biomarkers including daily EQ‐5D visual analogue scales and the bi‐weekly RhinAsthma Patient Perspective (RAAP). The potential implications for the management of allergic respiratory diseases were proposed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Allergology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- University Hospital Montpellier, Montpellier, France.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
- National Heart and Lung Institute (NHLI), Imperial College London, London, UK.
- NIHR Imperial Biomedical Research Centre, London, UK.
- ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.
ORCID-Profile: Jean Bousquet, Mohamed H Shamji, Stefano Del Giacco, Torsten Zuberbier, Oliver Pfaar, Ludger Klimek, Rita Amaral, Claudia Chaves Loureiro, Tari Haahtela, Paolo M Matricardi, Sanna Toppila-Salmi, Matteo Bonini, Louis-Philippe Boulet, Lorenzo Cecchi, Ivan Cherrez-Ojeda, Cemal Cingi, Alvaro A Cruz, Wytske J Fokkens, Enrico Heffler
Zitieren
APA
Bousquet, J., Shamji, M. H., Anto, J. M., Schünemann, H. J., Canonica, G. W., Jutel, M., Del Giacco, S., Zuberbier, T., Pfaar, O., Fonseca, J. A., Sousa-Pinto, B., Klimek, L., Czarlewski, W., Bedbrook, A., Amaral, R., Ansotegui, I. J., Bosnic-Anticevich, S., Braido, F., Chaves Loureiro, C., …, & Kraxner, H. (2023). Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report. Allergy, 78(7), 1758-1776. https://doi.org/10.1111/all.15740
Vancouver
Bousquet J, Shamji MH, Anto JM, Schünemann HJ, Canonica GW, Jutel M, et al. Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report. Allergy. 2023;78(7):1758-1776. doi:10.1111/all.15740
BibTeX
@article{Bousquet2023,
author = {Bousquet, Jean and Shamji, Mohamed H and Anto, Josep M and Schünemann, Holger J and Canonica, G Walter and Jutel, Marek and Del Giacco, Stefano and Zuberbier, Torsten and Pfaar, Oliver and Fonseca, Joao A and Sousa-Pinto, Bernardo and Klimek, Ludger and Czarlewski, Wienczyslawa and Bedbrook, Anna and Amaral, Rita and Ansotegui, Ignacio J and Bosnic-Anticevich, Sinthia and Braido, Fulvio and Chaves Loureiro, Claudia and Gemicioglu, Bilun and Haahtela, Tari and Kulus, Marek and Kuna, Piotr and Kupczyk, Maciej and Matricardi, Paolo M and Regateiro, Frederico S and Samolinski, Boleslaw and Sofiev, Mikhail and Toppila-Salmi, Sanna and Valiulis, Arunas and Ventura, Maria Teresa and Barbara, Cristina and Bergmann, Karl C and Bewick, Michael and Blain, Hubert and Bonini, Matteo and Boulet, Louis-Philippe and Bourret, Rodolphe and Brusselle, Guy and Brussino, Luisa and Buhl, Roland and Cardona, Victoria and Casale, Thomas and Cecchi, Lorenzo and Charpin, Denis and Cherrez-Ojeda, Ivan and Chu, Derek K and Cingi, Cemal and Costa, Elisio M and Cruz, Alvaro A and Devillier, Philippe and Dramburg, Stephanie and Fokkens, Wytske J and Gotua, Maia and Heffler, Enrico and Ispayeva, Zhanat and Ivancevich, Juan Carlos and Joos, Guy and Kaidashev, Igor and Kraxner, Helga},
title = {Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report},
journal = {Allergy},
year = {2023},
volume = {78},
number = {7},
pages = {1758--1776},
doi = {10.1111/all.15740}
}
EUVIMED